Cargando…
Targeted therapies in the management of metastatic bladder cancer
The management of metastatic urothelial carcinoma (UC) of the bladder is a common and complex clinical challenge. Despite the fact that UC is one of the most frequent tumors in the population, long term survival for metastatic disease remains low, and chemotherapy is curative for only a small minori...
Autores principales: | Fassan, Matteo, Trabulsi, Edouard J, Gomella, Leonard G, Baffa, Raffaele |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721287/ https://www.ncbi.nlm.nih.gov/pubmed/19707309 |
Ejemplares similares
-
Is there an optimal management for localized prostate cancer?
por: Singh, Jaspreet, et al.
Publicado: (2010) -
Rhabdomyolysis After Laparoscopic Nephrectomy
por: Glassman, Deborah T., et al.
Publicado: (2007) -
Mitostatin Is Down-Regulated in Human Prostate Cancer and Suppresses the Invasive Phenotype of Prostate Cancer Cells
por: Fassan, Matteo, et al.
Publicado: (2011) -
MITOSTATIN, a Putative Tumor Suppressor on Chromosome 12q24.1, is Down-regulated in Human Bladder and Breast Cancer
por: Vecchione, A, et al.
Publicado: (2008) -
Transperitoneal Robotic-Assisted Laparoscopic Prostatectomy After Prosthetic Mesh Herniorrhaphy
por: Lallas, Costas D., et al.
Publicado: (2009)